PeptidePedia The community reference

Resin cleavage (revision 7)

Old revision·13:17, 27 Oct 2024·ExternalLinksEli

This is an old revision of this page, as it stood at 13:17, 27 Oct 2024, saved by ExternalLinksEli with the summary fix a dangling clause. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Resin cleavage
Reagent, Fmoc chemistryTrifluoroacetic acid with scavengers
SimultaneousSide-chain deprotection
IsolationPrecipitation into cold ether
Analytical method infobox · conventions

Resin cleavage is the step that releases an assembled peptide from the solid support. In Fmoc chemistry it also removes the acid-labile side-chain protecting groups, so a single treatment with concentrated trifluoroacetic acid accomplishes both.[1]

The removed protecting groups generate reactive carbocations, which will alkylate electron-rich side chains — tryptophan, methionine, cysteine and tyrosine — unless captured. Scavengers are included in the cleavage cocktail for that purpose, and their selection depends on which residues the sequence contains.[1]

Cleavage is therefore not a neutral release step. It is a chemical operation with its own characteristic impurities, and a substantial part of the difference between a clean and a dirty crude is decided here.[2]

Cocktails and scavengers

[edit]

A typical cocktail is trifluoroacetic acid with a few per cent each of water, triisopropylsilane and, where cysteine or methionine is present, a thiol scavenger. Water and silane trap the tert-butyl and trityl cations; thiols address the more persistent species.[1]

Time and temperature are the other variables. Arginine's sulfonyl protecting groups are the slowest to remove, so a peptide rich in arginine requires longer treatment — during which more sensitive residues are exposed to acid for longer.

The trade-off is direct: insufficient time leaves protected species in the crude, excessive time generates degradation. This is one of the process choices that a certificate does not report but whose consequences it may show.[2]

References

  1. ^ a b c Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." Journal of Peptide Science 22(1):4–27 (2016). PMID 26785684.
  2. ^ a b United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.